Uncertain about uncertainty in matching-adjusted indirect comparisons? A simulation study to compare methods for variance estimation

被引:0
|
作者
Chandler, Conor O. [1 ]
Proskorovsky, Irina [1 ]
机构
[1] Evidera, Evidence Synth Modeling & Commun, 7101 Wisconsin Ave, Bethesda, MD 20814 USA
关键词
bootstrap; matching-adjusted indirect comparison; robust sandwich estimator; simulation study; uncertainty; variance; MARGINAL STRUCTURAL MODELS; BAYESIAN-ESTIMATION; TARGET ESTIMANDS; HETEROSKEDASTICITY; INFERENCE; SURVIVAL; METAANALYSIS;
D O I
10.1002/jrsm.1759
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In health technology assessment, matching-adjusted indirect comparison (MAIC) is the most common method for pairwise comparisons that control for imbalances in baseline characteristics across trials. One of the primary challenges in MAIC is the need to properly account for the additional uncertainty introduced by the matching process. Limited evidence and guidance are available on variance estimation in MAICs. Therefore, we conducted a comprehensive Monte Carlo simulation study to evaluate the performance of different statistical methods across 108 scenarios. Four general approaches for variance estimation were compared in both anchored and unanchored MAICs of binary and time-to-event outcomes: (1) conventional estimators (CE) using raw weights; (2) CE using weights rescaled to the effective sample size (ESS); (3) robust sandwich estimators; and (4) bootstrapping. Several variants of sandwich estimators and bootstrap methods were tested. Performance was quantified on the basis of empirical coverage probabilities for 95% confidence intervals and variability ratios. Variability was underestimated by CE + raw weights when population overlap was poor or moderate. Despite several theoretical limitations, CE + ESS weights accurately estimated uncertainty across most scenarios. Original implementations of sandwich estimators had a downward bias in MAICs with a small ESS, and finite sample adjustments led to marked improvements. Bootstrapping was unstable if population overlap was poor and the sample size was limited. All methods produced valid coverage probabilities and standard errors in cases of strong population overlap. Our findings indicate that the sample size, population overlap, and outcome type are important considerations for variance estimation in MAICs.
引用
收藏
页码:1094 / 1110
页数:17
相关论文
共 50 条
  • [41] Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
    Cooper, Miranda C.
    Kilvert, Hannah S.
    Hodgkins, Paul
    Roskell, Neil S.
    Eldar-Lissai, Adi
    CNS DRUGS, 2019, 33 (10) : 1039 - 1052
  • [43] Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy
    Wong, Emily C. L.
    Dulai, Parambir S.
    Marshall, John K.
    Jairath, Vipul
    Reinisch, Walter
    Narula, Neeraj
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 311 - 313
  • [44] Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
    Miranda C. Cooper
    Hannah S. Kilvert
    Paul Hodgkins
    Neil S. Roskell
    Adi Eldar-Lissai
    CNS Drugs, 2019, 33 : 1039 - 1052
  • [45] Generalizing some key results from "alternative weighting schemes when performing matching-adjusted indirect comparisons"
    Zhang, Landan
    Jackson, Dan
    RESEARCH SYNTHESIS METHODS, 2024, 15 (01) : 152 - 156
  • [46] Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
    Lu, Xiaoyan
    Zhou, Zheng-Yi
    Xin, Yiqiao
    Wang, Min-Jung
    Gray, Emma
    Jairath, Vipul
    Lindsay, James Oliver
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 64 - 77
  • [47] Matching-Adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Ibrutinib in Relapsed/ Refractory Mantle Cell Lymphoma
    Gaitonde, Priyanka
    Cai, Ling
    de Miranda, Paulo
    Roos, Jack
    Rule, Simon
    Wang, Michael L.
    BLOOD, 2022, 140 : 3646 - 3647
  • [48] Adis summary of research: Matching-adjusted indirect comparisons of diroximel fumarate, ponesimod, and teriflunomide for relapsing multiple sclerosis
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (07) : 239 - 240
  • [49] Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
    Jairath, Vipul
    Raine, Tim
    Leahy, Thomas P.
    Potluri, Ravi
    Wosik, Karolina
    Gruben, David
    Cappelleri, Joseph C.
    Hur, Peter
    Bartolome, Lauren
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (04)
  • [50] Matching-adjusted indirect comparisons of efficacy and safety of Acalabrutinib versus Ibrutinib in treatment-naive chronic lymphocytic leukemia
    Dietrich, S.
    Davids, M.
    Telford, C.
    Abhyankar, S.
    Waweru, C.
    Ringshausen, I.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 72 - 72